Perbedaan Communication Cable Systems Indonesia Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Communication Cable Systems Indonesia Tbk. diperdagangkan di Rp246 (kapitalisasi pasar 328 M, volume 24 jam 20,6 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp246 (kapitalisasi pasar 167,37 M, volume 24 jam 17,7 rb). Perbedaan utamanya: Communication Cable Systems Indonesia Tbk. lebih besar dari sisi kapitalisasi pasar, dan Communication Cable Systems Indonesia Tbk. lebih aktif diperdagangkan (20,6 rb vs 17,7 rb). Mana yang lebih baik tergantung tujuan investasimu.
| CCSI | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 328 M | 167,37 M |
Volume | 20,6 rb | 17,7 rb |
Lot | 206 | 177 |
Perputaran | 5,07 jt | 4,35 jt |
Harga Rata-rata | 246,04 | 246 |
Nilai Transaksi | 5,07 jt | 4,35 jt |
Harga Ekuilibrium Indikatif | 250 | 246 |
Volume Ekuilibrium Indikatif | 2 | 2,4 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Communication Cable Systems Indonesia Tbk (the Entity) Tbk formerly PT Siemens Kabel Optik was established under the framework of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11/1970, and most recently amended by Capital Investment No. 25/2007, based on the Notarial Deed No. 66 of Trisnawati Mulia, S.H., dated October 11, 1995.
Selengkapnya di halaman CCSI →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →